Mono Bar
Main page content

Provider Support


Find information, training, and support resources for practitioners using medication to treat all forms of substance use disorder (SUD).

Provider Support Contact

Practitioners with general information and training questions can contact SAMHSA's Provider Support Team at or call 1-866-287-2728.


Elimination of the DATA Waiver

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removed the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications such as buprenorphine, for the treatment of opioid use disorder (OUD).

For more information see Waiver Elimination (MAT Act).

Provider Education and Training

Section 1263 of the Consolidated Appropriations Act of 2023, also known as the MATE Act, requires practitioners applying for a new or renewed Drug Enforcement Administration (DEA) registration with Schedules II – V to attest that they have met these requirements:

  • Completed at least 8-hours of training (training can be cumulative; it does not have to be complete in one session) on opioid/other substance use disorders that has been approved by certain specified organizations; or
  • Hold a current board certification in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, American Board of Addiction Medicine, or the American Osteopathic Association; or
  • Graduated within five (5) years in good standing from a medical, advanced practice nursing, or physician assistant school in the United States that included successful completion of an opioid or other substance use disorder curriculum. Training must include the treatment and management of patients with opioid and other substance use disorders, and the appropriate clinical use of all drugs approved by the FDA for the treatment of a substance use disorder.

For more information see Training Requirements (MATE Act) Resources.

Development of Core Curriculum for Graduate Healthcare Education

In support of the Biden-Harris Administration’s 2022 National Drug Control Strategy (PDF | 2.6 MB) (NDCS) SAMHSA worked with the Office of National Drug Control Policy (ONDCP) and experts from the field to expand the SUD health professions workforce through development of a core curriculum on SUD for integration into all medical and health profession programs.

To build upon previous efforts, SAMHSA and ONDCP convened a panel of experts in August 2023 to review and draft core curricular elements or categories that should be incorporated into SUD curriculum.

Learn more about the core curriculum.

SAMHSA Training Resources

Last Updated
Last Updated: 02/13/2024
Last Updated